ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemia

Johnvesly Basappa, Mevlut Citir, Qian Zhang, Hong Y. Wang, Xiaobin Liu, Olga Melnikov, Hafiz Yahya, Frank Stein, Rainer Muller, Alexis Traynor-Kaplan, Carsten Schultz, Mariusz A. Wasik, Andrzej Ptasznik

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'ACLY is the novel signaling target of PIP<sub>2</sub>/PIP<sub>3</sub> and Lyn in acute myeloid leukemia'. Together they form a unique fingerprint.

Chemical Compounds